US Patent Issued to Merck Sharp & Dohme on Aug. 4 for "Anti-respiratory syncytial virus (RSV) antibody cell-based potency assay" (Pennsylvania, Utah, New Jersey, California Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,503, issued on Aug. 4, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Anti-respiratory syncytial virus (RSV) antibody cell-based potency assay" was invented by Dai Wang (West Point, Pa.), John P. Bilello (San Carlos, Calif.), Kevin B. Gurney (Vineyard, Utah), Ping Han (Kenilworth, N.J.), Xi He (West Point, Pa.), Dengyun Sun (Kenilworth, N.J.) and Amy Hsu Tou (Kenilworth, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure describes methods for measuring the potency of anti-Respiratory Syncytial Virus (RSV) antibody against respiratory syncytial virus in a cell culture system using an RSV reporter virus. The disclosure also de...